Latest profit margin
Halozyme Therapeutics Profit margin
Direct answer
Halozyme Therapeutics's profit margin is 24.86%.
The verified market snapshot reports 24.86%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Profit margin
- 24.86%
Explore related company data
View Halozyme Therapeutics's market capitalizationView Halozyme Therapeutics's p/e ratioView Halozyme Therapeutics's price-to-book ratioView Halozyme Therapeutics's return on equityView Halozyme Therapeutics's dividend yieldView Halozyme Therapeutics's 52-week price rangeView Halozyme Therapeutics's revenue growthView Halozyme Therapeutics's debt-to-equity ratioView all Halozyme Therapeutics key metricsReturn to Halozyme Therapeutics profile